From enabling personalised medicine to accelerating the drug development pathway, 3D printing offers huge potential in pharmaceutical manufacturing. In order to embrace this new world of opportunities, we need a deeper understanding of the materials, processes and techniques involved.

Information on the most effective use of excipients, for example, has, until now, been lacking. But a model of collaborative working, that has led to this detailed study on printed lactose, is starting to change that. While this area of research is still in its infancy and every use case is unique, the research set out in this whitepaper shows that lactose – and collaboration – are yielding results.

We now invite industry, innovators and academia alike to review the data and to continue working together with us to develop a deeper understanding of the 3D printing of pharmaceuticals. By pooling knowledge and expertise, we can quickly and efficiently build the evidence base we need to contribute to timely, patient-centred medicine development.